USE OF THROMBOLYTIC AGENTS - CHOICE OF PATIENT, DRUG ADMINISTRATION, LABORATORY MONITORING
USE OF THROMBOLYTIC AGENTS - CHOICE OF PATIENT, DRUG ADMINISTRATION, LABORATORY MONITORING
复制标题
DOI：
10.7326/0003-4819-90-5-802
复制
发表时间：
1979-01-01
影响因子：
39.2
通讯作者：
MARDER, VJ
中科院分区：
文献类型：
--
作者：
MARDER, VJ
选择合适的患者对于确保满意的血栓或栓子溶解程度和不并发严重出血的临床病程至关重要。有血栓或栓子但没有可能出血的解剖损害的严重和急性疾病患者最好通过标准疗程给予溶栓剂，即链激酶法。治疗可以通过与溶血状态文件有关的简化实验室测试来监测。
A proper choice of patient is critical in assuring both a satisfactory degree of thrombus or embolus lysis and a clinical course uncomplicated by serious hemorrhage. Serious and acutely ill patients, with thrombus or embolus but without anatomic lesions which may hemorrhage are best treated by thrombolytic agents, i.e., streptokinase, administered by a standard course of therapy. Treatment can be monitored by simplified laboratory tests concerned with lytic state documentation.